
Surgery Partners (SGRY) Stock Forecast & Price Target
Surgery Partners (SGRY) Analyst Ratings
Bulls say
Surgery Partners is viewed as fundamentally attractive because its scaled ambulatory surgery center platform sits in an underpenetrated market where payors are pushing more procedures to lower-cost outpatient settings, supporting durable volume growth. Its 120 consolidated facilities, leadership in high-acuity specialties, and management’s confidence in sustaining double-digit EBITDA growth are reinforced by Medicare rule changes that could expand the addressable market and by continued OR and physician recruitment investment. The company’s strategic value is further highlighted by takeover interest at about 14.2x to 14.4x FY27 EBITDA, alongside Bain’s 39% ownership support and a credible path to higher growth without changing its core fee-for-service model.
Bears say
Surgery Partners is facing a structurally pressured operating backdrop where mature fee-for-service providers are contending with higher staffing costs, turnover, and reimbursement that generally lags, which can compress margins even as demand and patient volume have recently recovered. The sustainability of that rebound remains uncertain, while more onerous CMS reimbursement and regulatory provisions for home health and Medicare Advantage underscore a broader payer environment that can remain restrictive. On top of that, the company’s outlook is burdened by managed care and Medicare dependence, integration and recruitment risk, labor inflation, revenue concentration, and meaningful balance sheet leverage, with the downside case implying roughly a 10.7x FY27 adjusted EBITDA-MI multiple.
This aggregate rating is based on analysts' research of Surgery Partners and is not a guaranteed prediction by Public.com or investment advice.
Surgery Partners (SGRY) Analyst Forecast & Price Prediction
Start investing in Surgery Partners (SGRY)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Surgery Partners (SGRY) Forecast
Surgery Partners (SGRY) Analyst Forecast & Price Prediction
Start investing in Surgery Partners (SGRY)
Order type
Buy in
Order amount
Est. shares
0 shares